Jeff Johnson
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
-
- Cancer-related Molecular Pathways
- Viral-associated cancers and disorders
Papers in
- Oncology 7
- CAR-T cell therapy research 3
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Graeme Milligan (2 shared papers)René Bernards (1 shared paper)Ultan McDermott (1 shared paper)Lodewyk F.A. Wessels (1 shared paper)Mathew J. Garnett (1 shared paper)Bram Thijssen (1 shared paper)Allan Green (2 shared papers)John Lowe (1 shared paper)
- Journals
- Blood (3 papers)Physiotherapy (2 papers)Cancer (1 paper)Business Horizons (1 paper)Biochemical Society Transactions (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Jeff Johnson
27 papers receiving 683 citations
Peers
Comparison fields: 5 of 102
- Physiology 59
- Oncology 158
- Pathology and Forensic Medicine 101
- Critical Care and Intensive Care Medicine 21
- Molecular Biology 261
Countries citing papers authored by Jeff Johnson
This map shows the geographic impact of Jeff Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Johnson more than expected).
Fields of papers citing papers by Jeff Johnson
This network shows the impact of papers produced by Jeff Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Johnson. The network helps show where Jeff Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 153 | |
| 2 | 1990 | 113 | |
| 3 | 1991 | 77 | |
| 4 | The Small Business Owner-Manager's Search for External Information | 1987 | 70 |
| 5 | 1990 | 52 | |
| 6 | 2007 | 50 | |
| 7 | 1991 | 41 | |
| 8 | 1998 | 27 | |
| 9 | 1989 | 19 | |
| 10 | Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma. | 1986 | 18 |
| 11 | 1989 | 17 | |
| 12 | 2000 | 14 | |
| 13 | 1990 | 12 | |
| 14 | 1993 | 12 | |
| 15 | 1999 | 9 | |
| 16 | 2004 | 9 | |
| 17 | 2006 | 6 | |
| 18 | 2006 | 5 | |
| 19 | 1998 | 2 | |
| 20 | 1990 | 2 |
About Jeff Johnson
Jeff Johnson is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 715 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Adenosine and Purinergic Signaling (4 papers), CAR-T cell therapy research (3 papers), Adipose Tissue and Metabolism (3 papers), Microscopic Colitis (2 papers), Lung Cancer Treatments and Mutations (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (2 papers). The work is most often cited by research in Physiology (59 citations), Oncology (158 citations), Pathology and Forensic Medicine (101 citations), Critical Care and Intensive Care Medicine (21 citations) and Molecular Biology (261 citations). Jeff Johnson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Graeme Milligan, René Bernards, Ultan McDermott, Lodewyk F.A. Wessels, Mathew J. Garnett, Bram Thijssen, Allan Green, John Lowe, Robert Archer and Peter F. Moore. Their work appears in journals such as Blood, Physiotherapy, Cancer, Business Horizons and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.